We are a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.
Established in 1973, and headquartered in Mumbai, we produce high-quality branded generics, generic drugs, active pharmaceutical ingredients (“APIs”) and neutraceuticals, which we market in India and 55 countries internationally, primarily the United States
With a portfolio of over 700 brands in India, Alkem has been ranked among the Top Ten pharmaceutical companies in India in terms of domestic sales for the past 13 years.
We have a total of 16 manufacturing facilities: 14 manufacturing facilities are at geographically diversified locations in India and two in the United States. Out of the Indian manufacturing facilities, 12 are for the manufacture of formulations and two are for the manufacture of APIs. Six of our facilities are USFDA, TGA and UK-MHRA approved.
We have strong research and development capabilities which enhance our portfolio of products. We have four research and development facilities, two in India and two in the United States.
We strongly believe in extending Lifecare…beyond boundries.